Molecular Genetics & Genomic Medicine (Jul 2022)

A monoallelic variant in EYA1 is associated with Branchio‐Otic syndrome in a Malian family

  • Abdoulaye Yalcouyé,
  • Oumou Traoré,
  • Salimata Diarra,
  • Isabelle Schrauwen,
  • Kevin Esoh,
  • Magda Kamila Kadlubowska,
  • Thashi Bharadwaj,
  • Samuel Mawuli Adadey,
  • Mohamed Kéita,
  • Cheick O. Guinto,
  • Suzanne M. Leal,
  • Guida Landouré,
  • Ambroise Wonkam

DOI
https://doi.org/10.1002/mgg3.1995
Journal volume & issue
Vol. 10, no. 7
pp. n/a – n/a

Abstract

Read online

Abstract Background Branchio‐otic syndrome (BO) is one of the most common types of syndromic hearing impairment (HI) with an incidence of 1/40,000 globally. It is an autosomal dominant disorder typically characterized by the coexistence of branchial cysts or fistulae, malformations of the external, middle, and inner ears with preauricular pits or tags and a variable degree of HI. Most cases of BO have been reported in populations of European ancestry. To date, only few cases have been reported in people from African descent. Methods After a careful clinical examination, a pure tone audiometry was performed. DNA was extracted from peripheral blood and whole exome, and Sanger sequencing were performed for genetic analysis. Results Eight individuals from a large non‐consanguineous Malian family, with autosomal dominant inheritance were enrolled. The ages at diagnosis ranged from 8 to 54 years. A high phenotypic variability was noted among the affected individuals. Four patients presented with a post‐lingual and mixed type of HI, one individual had conductive HI while three had normal hearing but presented other BO features namely branchial fistulae and preauricular sinus. Serum creatinine level and renal ultrasonography were normal in three affected individuals who performed them. Genetic testing identified a monoallelic pathogenic variant in EYA1 (c.1286A > G; p.Asp429Gly) segregating with BO syndrome in the family. Conclusion This is the first genetically confirmed case of BO syndrome caused by EYA1 variant in the sub‐Saharan African population, expanding the genetic spectrum of the condition.

Keywords